Вячеслав Александрович Белов

Вячеслав Александрович Белов

Auto-generated profile, based on publicly available information

Вячеслав Александрович Белов

Federal Center for Cardiovascular Surgery named after S.G. Sukhanov, Ministry of Health of the Russian Federation, Perm

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in Creative surgery and oncology
Verified
Journal Article
Open access
PDF file
Soslan Taisumovich EnginoevSoslan Taisumovich Enginoev
Soslan Taisumovich Enginoev
ICI. I. Chernov
I. I. Chernov
RKRoman Komarov
Roman Komarov
VBV. A. Belov
V. A. Belov
VAV. B. Arutyunyan
V. B. Arutyunyan
AGA. B. Gamzaev
A. B. Gamzaev
Introduction. One of surgical methods for treatment of aortic valve (AV) pathology is Aortic Valve Neocuspidalization Ozaki procedure (AVNeo). Thus, according to the latest systematic review, freedom from reoperation within one, three, five years after AVNeo was 98%, 97% and 96%. Available references provide few descriptions of reoperations after AVNeo. Aim. To analyze the immediate results of AV reinterventions after AVNeo. Materials and methods. In the medium term, reinterventions after AVNeo were necessary for 11 patients (4.3%). The age of patients ranged from 26 to 69 years. 11 patients who underwent surgery included 6 males and 5 females. Four patients had class III-IV CHF, according to NYHA classification. Three patients had previously been operated on for infective endocarditis (IE), and five patients had bicuspid aortic valve. The duration of follow-up, from AVNeo surgery to reinterventions, ranged from 3 to 43 months. Results and discussion. All patients underwent an isolated AV intervention. The main causes of dysfunction were IE (six patients) and leaflet rupture in the commissural area (five patients). Seven patients underwent aortic valve replacement with mechanical valves, one patient — with aortic homograft valve, one patient — with tissue valve and two patients underwent valve repair. In the early postoperative period, one patient had bleeding with the development of cardiac tamponade and one patient had a haemorrhagic stroke. No patients had ARF, perioperative myocardial damage, sternal infection or permanent pacemaker implantation. Two patients died during the hospital period. Conclusions. AV reinterventions are associated with a high incidence of complications and deaths. Therefore, prevention of IE and commissure enhancement should reduce the frequency of repeated interventions, which is to be confirmed by prospective studies in large cohorts of patients.

25 June 2023 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
RKRoman Komarov
Roman Komarov
МНМихаил Дмитриевич Нуждин
Михаил Дмитриевич Нуждин
ВБВячеслав Александрович Белов
Вячеслав Александрович Белов
SCStanislav V. Chernyavsky
Stanislav V. Chernyavsky
AIAlisher M. Ismailbayev
Alisher M. Ismailbayev
LBLusine R. Baziyants
Lusine R. Baziyants
HighlightsThe article presents the latest data on the techniques of implantation of the mitral homograft in the tricuspid position, and identifies groups of patients who are best suited for this method. Moreover, the article describes the evolution of this type of replacement, and highlights that many surgical techniques, although justified, require further study to show demonstrate their advantages. AbstractDespite the general trend in cardiac surgery towards valve-preserving interventions, valve replacements remain relevant, and the search for the perfect prosthetic valve continues. Many believe that tricuspid valve replacement using a mitral homograft can be the method of choice in certain situations. The analysis of the studies found in the PubMed database led the authors to the following conclusions: most of the data on the use of this technique in patients with infective endocarditis (IE), other indications are congenital heart disease (CHD) and rheumatic heart disease. Patients with IE who have undergone tricuspid valve replacement using a mitral homograft have good medium-term prospects, and respond well to medical treatment of recurrent IE. The mitral homograft in the tricuspid position remains intact even after prosthetic endocarditis. In this regard, it is possible to perform reconstructive intervention in case of prosthetic valve dysfunction without the need for repeated replacement. Such interventions are relevant for patients with growing heart for whom annuloplasty at the first stage of surgery is undesirable. Moreover, it is also cost-effective due to the high cost and low availability of homografts. The possibility of repeated tricuspid valve-in-valve replacement is important for patients who may not survive open surgery. To date, there are not enough long-term and short-term data on using a mitral homograft for tricuspid valve replacement, however, it can be assumed that the results of this technique will be positive provided that the appropriate implantation technique and strict patient selection are ensured. Many authors have come to the conclusion that the optimal homograft implantation technique includes sewing of the graft`s papillary muscles into the wall of the myocardium of the right ventricle (RV), fixating them on the outer surface of the RV, anatomical positioning of the homograft (anterior leaflet faces towards the IVS), and the use of an annuloplasty ring.

20 May 2025 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
SLS. Kh. Lilotkhia
S. Kh. Lilotkhia
RKRoman Komarov
Roman Komarov
VAV. B. Arutyunyan
V. B. Arutyunyan
VBV. A. Belov
V. A. Belov
Aim. To conduct an in-depth comparative analysis of the impact of preoperative profile and range of surgical techniques in coronary artery bypass grafting (CABG) surgery on shortand long-term outcomes in women and men.Material and methods. This retrospective and prospective single-center CROWNSAGA study (NCT06749171) includes a sample of 400 patients (200 women and 200 men) who underwent CABG in the period from January 2016 to July 2023 at the Sukhanov Federal Center for Cardiovascular Surgery (Perm). The patients included in the study were divided into groups by sex followed by propensity score matching (PSM) analysis, as well as into stratum of surgical techniques — on-pump coronary artery bypass grafting (ONCAB), off-pump coronary artery bypass grafting (OPCAB), no-touch aorta technique (NTA), minimally invasive multiple coronary artery bypass grafting (MICSCAB). Furthermore, the impact of multiple arterial grafting (MAG), total arterial revascularization (TAR), composite and sequential grafting on outcomes was analyzed for each sex. The primary endpoint was a composite of allcause mortality, myocardial infarction (MI), stroke or transient ischemic attack (TIA) and repeat revascularization (major adverse cardiovascular and cerebrovascular events, MACCE) during the long-term follow-up. The secondary endpoint was allcause mortality during the long-term follow-up.Results. Median follow-up duration was 50 (1st (Q1) and 3rd (Q3) quartiles: 30; 72) months: 54,5 (33; 75,8) in women and 46 (22; 71) in men. Women had less favorable preoperative profile compared to men. Short-term in-hospital outcomes were comparable between women and men in terms of mortality (2,5% vs 3,5%) and MACCE (1% vs 1,5%). Over long-term follow-up, the incidence of MACCE was 21,2% in women and 16,2% in men (hazard ratio (HR) =1,15 [95% confidence interval (CI): 0,72; 1,82], p=0,557) and the incidence of death was 11,1% in women and 10,2% in men (HR =0,94 [95% CI: 0,51; 1,72], p=0,83). Female cohort had higher risks of MI (HR =6,66 [95% CI: 0,83; 53,28], p=0,038), revascularization (HR =4,11 [95% CI: 1,18; 14,32], p=0,016) and stroke (HR =1,24 [95% CI: 0,59; 2,6], p=0,567). In the all off-pumps strata (OPCAB, NTA, MICSCAB) compared with ONCAB, risk of adverse long-term outcomes was higher among all patients in regard to both MACCE (HR =1,54 [95% CI: 0,95; 2,49], p=0,08) and death (HR =2,17 [95% CI: 1,14; 4,14], p=0,016). No significant difference was observed in longterm MACCE and death rates between women or men when comparing ONCAB, OPCAB, MICSCAB and NTA stratum, except for a significant lower risk of death in men with ONCAB compared to OPCAB (HR =0,28 [95% CI: 0,09; 0,91], p=0,03). The use of graft imaging revealed an increased risk of graft occlusion in women, whereas following off-pump CABG the risk of any occlusion was significantly higher in both sexes compared to ONCAB. Predictor of long-term MACCE and death for women was use of composite grafts, while for men — ejection fraction (EF) £40%, age >70 years, and off-pump CABG. At last follow-up, the persistence of health complaints was significantly higher among female patients versus male patients.Conclusion. Women overall have less favorable outcomes following surgical myocardial revascularization compared with men. The impact of different surgical bypass techniques on postoperative outcomes varies between women and men. A differential sex-gender approach should be employed in the selection of the optimal surgical technique for CABG, with the objective of improving patient outcomes following myocardial revascularization.

5 December 2024 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
BKB. K. Kadyraliev
B. K. Kadyraliev
VBV. A. Belov
V. A. Belov
AMA. V. Marchenko
A. V. Marchenko
VAV. B. Arutyunayan
V. B. Arutyunayan
ICI. I. Chernov
I. I. Chernov
Soslan Taisumovich EnginoevSoslan Taisumovich Enginoev
Soslan Taisumovich Enginoev
In aortic valve (AV) replacement surgery in patients with a narrow annulus fibrosus (AF), the likelihood of prosthesis-patient mismatch (PPM) is high. PPM, in turn, significantly affects the hemodynamic and functional capabilities of AV, morbidity and mortality in the postoperative period. The “gold standard” for the treatment of AV diseases is prosthetics with mechanical and biological prostheses. However, there are alternative methods, such as neocuspidalization of AV according to the S. Ozaki (AVNeo) method.Aim: To compare the immediate and medium-term results of AV prosthetics using the S. Ozaki (AVNeo) technique and AV prosthetics with a biological prosthesis in patients with a small aortic annulus.Material and Methods: A retrospective multicenter study of 309 patients with a narrow fibrous ring of the aortic valve (FR AV) who underwent surgery between February 2010 and December 2021 was conducted. Inclusion criteria: prosthetics of AV, FR AV = 21 mm, age 18 years and older. Exclusion criteria: left ventricle ejection fraction ≤ 40%, repeated interventions, mini-stop. 153 patients underwent Aveo and 156 patients underwent AV prosthetics using biological prostheses. After “pseudorandomization” (propensity score matching), 92 patients were selected: 46 patients in the AVNeo group and 46 patients in the biological prosthesis group. The primary endpoint was hospital mortality. Postoperative complications, transvalvular gradients, and medium-term outcomes (three-year overall survival and freedom from surgery on AV) were evaluated as secondary endpoints.Results. There was no statistically significant difference in the duration of surgery (275.9 ± 34.2 min in the AVNeo group and 285.8 ± 37 min in the bioprosthesis group, p < 0.4), artificial circulation (98 min in the AVNeo group and 115 min in the bioprosthesis group, p < 0.3), aortic compression (80 min in the AVNeo group and 93 min in the bioprosthesis group, p < 0.7). Hospital mortality among the studied patients did not differ: in the AVNeo group – 2 (4.3%) and 1 (2.2%) in the bioprosthesis group, p = 1.0. There were no significant differences in postoperative complications: wound surface infection (3 (6.5%) in the AVNeo group and 1 (2.2%) in the bioprosthesis group, p = 0.617), acute kidney injury (1 (2.2%) in the AVNeo group and 0 in the bioprosthesis group, p = 1.0), stroke ( 1 (2.2%) in the AVNeo group and 2 (4.3%) in the bioprosthesis group, p = 1.0), resternotomy for bleeding (0 in the AVNeo group and 2 (4.3%) in the bioprosthesis group, p = 0.495). Permanent pacemaker implantation was not required by any patient. There was also no statistically significant difference in the three-year overall survival and re–operation, in the AVNeo group it was 83% and 92.5% in the bioprosthesis group, p = 0.23; three-year freedom from re-operation was 96.4% in the AVNeo group and 97.1% in the bioprosthesis group, p = 0.27. However, peak and average gradients were statistically less after AVNeo surgery. The peak and average gradients after AVNeo were 12 and 6 mmHg, after prosthetics 32 and 20 mmHg, p < 0.001.Conclusions: There was no statistically significant difference in hospital mortality, postoperative complications, and three-year survival and re-operation. The values of the peak and average pressure gradient at discharge differed statistically significantly in favor of the AVNeo group.

4 December 2024 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
RKR. D. Khuziakhmetov
R. D. Khuziakhmetov
ESE. A. Shishkina
E. A. Shishkina
BKB. K. Kadyraliev
B. K. Kadyraliev
VBV. A. Belov
V. A. Belov
SAS. N. Azizov
S. N. Azizov
OKO. V. Khlynova
O. V. Khlynova
Atrial fibrillation (AF) is the most common arrhythmia among the adult population, affecting up to 2% of the population. Among patients with chronic heart failure (CHF), the prevalence of AF reaches 12.3%. The presence of common risk factors and pathophysiological mechanisms of AF and CHF development lead to the frequent combination of these two pathologies, which has a negative impact on the course of the underlying disease and further prognosis, increasing the chances of adverse outcomes such as stroke, myocardial infarction, and cardiovascular mortality. The results of most randomized studies indicate that interventional treatment of AF in patients with CHF and intermediate to low left ventricular ejection fraction (LV) contributes to reducing the functional class of CHF and improving quality of life, but at the same time, there is currently no consensus on the effectiveness, safety, and extent of catheter intervention. In this review, we attempted to summarize the literature data regarding the outcomes of interventional treatment of AF in patients with systolic LV dysfunction.

22 January 2024 in Perm Medical Journal
Verified
Journal Article
Open access
PDF file
BKB. К. Kadyraliev
B. К. Kadyraliev
VBV. А. Belov
V. А. Belov
VAV. B. Arutyunyan
V. B. Arutyunyan
АMА. V. Marchenko
А. V. Marchenko
NKN. V. Kdralieva
N. V. Kdralieva
Alex G. KuchumovAlex G. Kuchumov
Alex G. Kuchumov
Objective. To analyze the immediate and medium-term results of prosthetics of the aortic valve (AV) using biological prosthesis in elderly patients. Material and methods. The study included 198 patients with AV pathology [85 men (42.9 %)/113 women (57.1 %)]. The median age was 70 [66–73] years. There were 175 (88.4 %) patients with sclerodegenerative AV, 5 (2.5 %) – with infectious endocarditis and 30 patients (15.2 %) had bicuspid AV. Results. The hospital mortality was 4.5 %. The causes of mortality were multiple organ failure syndrome, in 1 case – developed peritonitis. In 14 patients (7.1 %) there was a rhythm disturbance in the form of AF, in 9 (4.5 %) – a complete AV block, in connection with which a permanent pacemaker was implanted. Four patients (2 %) underwent resternotomy for bleeding. Two patients (1 %) underwent pericardiocentesis. 8 (4 %) patients developed a stroke. No wound complications were detected. In the long-term period, 31 patients died. The causes of mortality were the following: cardiovascular diseases – 13 patients, malignant neoplasms – 5 patients, gastrointestinal diseases – 2, urinary system disease – 1 patient, COVID-19 – 1 patient, unknown cause – 9 patients. Thus, the five-year survival rate after the surgery was 63 %, respectively. During the follow-up period, 2 patients (2.9 %) underwent repeated intervention on AV. Conclusions. The five-year freedom from re-operation was 97.1 %. The five-year survival rate was 63 % due to the presence of a history of severe concomitant pathology as well as the middle age of patients 70 years.